These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
828 related articles for article (PubMed ID: 25393304)
1. Predictive value of interferon-lambda gene polymorphisms for treatment response in chronic hepatitis C. Susser S; Herrmann E; Lange C; Hamdi N; Müller T; Berg T; Perner D; Zeuzem S; Sarrazin C PLoS One; 2014; 9(11):e112592. PubMed ID: 25393304 [TBL] [Abstract][Full Text] [Related]
2. Strong prediction of virological response to combination therapy by IL28B gene variants rs12979860 and rs8099917 in chronic hepatitis C genotype 4. Ragheb MM; Nemr NA; Kishk RM; Mandour MF; Abdou MM; Matsuura K; Watanabe T; Tanaka Y Liver Int; 2014 Jul; 34(6):890-5. PubMed ID: 24102823 [TBL] [Abstract][Full Text] [Related]
3. Polymorphism of the IL28B gene (rs8099917, rs12979860) and virological response of Pakistani hepatitis C virus genotype 3 patients to pegylated interferon therapy. Aziz H; Raza A; Ali K; Khattak JZ; Irfan J; Gill ML Int J Infect Dis; 2015 Jan; 30():91-7. PubMed ID: 25462177 [TBL] [Abstract][Full Text] [Related]
4. Role of IL28B genotyping in patients with hepatitis C virus-associated mixed cryoglobulinemia and response to PEG-IFN and ribavirin treatment. Boglione L; Cusato J; Allegra S; Cariti G; Di Perri G; D'Avolio A Arch Virol; 2015 Aug; 160(8):2009-17. PubMed ID: 26060059 [TBL] [Abstract][Full Text] [Related]
5. Association between CXCL10 and DPP4 Gene Polymorphisms and a Complementary Role for Unfavorable IL28B Genotype in Prediction of Treatment Response in Thai Patients with Chronic Hepatitis C Virus Infection. Thanapirom K; Suksawatamnuay S; Sukeepaisarnjaroen W; Tangkijvanich P; Treeprasertsuk S; Thaimai P; Wasitthankasem R; Poovorawan Y; Komolmit P PLoS One; 2015; 10(9):e0137365. PubMed ID: 26339796 [TBL] [Abstract][Full Text] [Related]
6. Sustained virologic response and IL28B single-nucleotide polymorphisms in patients with chronic hepatitis C treated with pegylated interferon alfa and ribavirin. Jabłonowska E; Piekarska A; Koślińska-Berkan E; Omulecka A; Szymańska B; Wójcik K Acta Biochim Pol; 2012; 59(3):333-7. PubMed ID: 22924160 [TBL] [Abstract][Full Text] [Related]
7. Meta-analysis: IL28B polymorphisms predict sustained viral response in HCV patients treated with pegylated interferon-α and ribavirin. Chen Y; Xu HX; Wang LJ; Liu XX; Mahato RI; Zhao YR Aliment Pharmacol Ther; 2012 Jul; 36(2):91-103. PubMed ID: 22591106 [TBL] [Abstract][Full Text] [Related]
9. Telaprevir is effective given every 12 h at 750 mg with pegylated interferon-α2b and ribavirin to Japanese patients with HCV-1b IL28B rs8099917 TT. Kawakami Y; Suzuki F; Karino Y; Toyota J; Kumada H; Chayama K Antivir Ther; 2014; 19(3):277-85. PubMed ID: 24192751 [TBL] [Abstract][Full Text] [Related]
10. KIR3DL1-HLA-Bw4 combination and IL28B polymorphism predict response to Peg-IFN and ribavirin with and without telaprevir in chronic hepatitis C. Umemura T; Ota M; Katsuyama Y; Wada S; Mori H; Maruyama A; Shibata S; Nozawa Y; Kimura T; Morita S; Joshita S; Komatsu M; Matsumoto A; Kamijo A; Kobayashi M; Takamatsu M; Yoshizawa K; Kiyosawa K; Tanaka E Hum Immunol; 2014 Aug; 75(8):822-6. PubMed ID: 24929144 [TBL] [Abstract][Full Text] [Related]
11. The impact of genetic variation in IL28B, IFNL4 and HLA genes on treatment responses against chronic hepatitis C virus infection. Sakhaee F; Ghazanfari M; Vaziri F; Jamnani FR; Davari M; Gharibzadeh S; Fateh R; Abdolrahimi F; Dizaji SP; Fateh A; Siadat SD Infect Genet Evol; 2017 Oct; 54():330-337. PubMed ID: 28739427 [TBL] [Abstract][Full Text] [Related]
12. Interferon-λ3 polymorphisms in pegylated-interferon-α plus ribavirin therapy for genotype-2 chronic hepatitis C. Ishiguro H; Abe H; Seki N; Sugita T; Aida Y; Itagaki M; Sutoh S; Shimada N; Furihata T; Tsubota A; Aizawa Y World J Gastroenterol; 2015 Apr; 21(13):3904-11. PubMed ID: 25852275 [TBL] [Abstract][Full Text] [Related]
13. Value of interleukin-28B genetic polymorphism on retreatment outcomes of chronic hepatitis C genotype 1 relapsers by peginterferon alfa plus ribavirin. Chen MY; Liu CH; Chen TC; Su TH; Chen PJ; Chen DS; Kao JH; Liu CJ J Gastroenterol Hepatol; 2014 Jan; 29(1):102-9. PubMed ID: 23829453 [TBL] [Abstract][Full Text] [Related]
14. IL28B rs12980275 variant as a predictor of sustained virologic response to pegylated-interferon and ribavirin in chronic hepatitis C patients: A systematic review and meta-analysis. Zheng H; Li M; Chi B; Wu XX; Wang J; Liu DW Clin Res Hepatol Gastroenterol; 2015 Oct; 39(5):576-83. PubMed ID: 25769643 [TBL] [Abstract][Full Text] [Related]
15. Interferon-λ polymorphisms and response to pegylated interferon in Iranian hepatitis C patients. Haj-Sheykholeslami A; Keshvari M; Sharafi H; Pouryasin A; Hemmati K; Mohammadzadehparjikolaei F World J Gastroenterol; 2015 Aug; 21(29):8935-42. PubMed ID: 26269684 [TBL] [Abstract][Full Text] [Related]
16. IL28B polymorphisms determine early viral kinetics and treatment outcome in patients receiving peginterferon/ribavirin for chronic hepatitis C genotype 1. Lindh M; Lagging M; Arnholm B; Eilard A; Nilsson S; Norkrans G; Söderholm J; Wahlberg T; Wejstål R; Westin J; Hellstrand K J Viral Hepat; 2011 Jul; 18(7):e325-31. PubMed ID: 21692944 [TBL] [Abstract][Full Text] [Related]
17. High resolution melting curve assay for detecting rs12979860 IL28B polymorphisms involved in response of Iranian patients to chronic hepatitis C treatment. Fateh A; Aghasadeghi MR; Keyvani H; Mollaie HR; Yari S; Hadizade Tasbiti AR; Ghazanfari M; Monavari SH Asian Pac J Cancer Prev; 2015; 16(5):1873-80. PubMed ID: 25773839 [TBL] [Abstract][Full Text] [Related]
18. Impact of IFNL4 rs12979860 and rs8099917 polymorphisms on response to Peg-Interferon-α and Ribavirin in patients with congenital bleeding disorder and chronic hepatitis C. Keshvari M; Alavian SM; Behnava B; Pouryasin A; Craig JC; Sharafi H J Clin Lab Anal; 2017 Jul; 31(4):. PubMed ID: 27735085 [TBL] [Abstract][Full Text] [Related]
19. Role of interleukin-28B polymorphism as a predictor of sustained virological response in patients with chronic hepatitis C treated with triple therapy: a systematic review and meta-analysis. Bota S; Sporea I; Şirli R; Neghină AM; Popescu A; Străin M Clin Drug Investig; 2013 May; 33(5):325-31. PubMed ID: 23532802 [TBL] [Abstract][Full Text] [Related]
20. IL28B polymorphisms predict the response to chronic hepatitis C virus infection treatment in a Mexican population. Martínez-Gómez LE; Chávez-Tapia NC; Burguete-García AI; Aguilar-Olivos N; Madrid-Marina V; Román-Bahena M; Orbe-Orihuela C; Misael U; Méndez-Sánchez N Ann Hepatol; 2012; 11(6):876-81. PubMed ID: 23109451 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]